Science Pills

Amblyopia (Lazy eye)

What is ambliopia, risks and prevalance

What is it?

Risks
Over time, the brain relies more and more on the strong eye while vision in the weaker eye gets worse
Amblyopia can lead to lifelong impairment in the weak eye and lifelong impaired depth perception and associated fine motor skills.
Amblyopia is associated to a risk of visual loss from 1.2% to 2.9%

Clinical assessment of amblyopia

What causes amblyopia?

A complete clinical assessment of the oculomotor and visual system leads to diagnosis of one of three types of causes for amblyopia:

There are neural correlates of amblyopia?

Comparisons with non-amblyopic showed significant difference in the neural activities of retina , lateral geniculate bodies, visual and temporal cortex

What are amblyopia risk factors?

What is amblyopia prevalence in children?

The overall worldwide prevalence of amblyopia in children is about 1.36%, higher in in males (1.40%) than in females (1.24%).

 The highest prevalence estimate is observed in Europe, the lowest in Africa (0.51%), but it is still unclear whether these differences are statistically significative.

In 2019 were estimated about 99 million people with amblyopia, estimate to encrease to 175 million by 2030 and 222 million by 2040.

How is treated amblyopia

Once recognized the type of Amblyopia, the first step is always to address the cause (e.g with refractive correction in animesotropia)

The best-established treatment for amblyopia is occlusion therapy, that consists in depriving the healthy eye of  visual input by patching or by optical or pharmaceutical penalization (atropine).

Recently also amblyopia digital treatments become popular.

Patching

According to the severity of amblyopia the strong eye is patched for a variable amount of time:

Atropine

Atropine blocks parasympathetic innervation of the pupil and ciliary muscle by reducing the action of the neurotransmitter acetylcholine [3].

It is  used  as  a  1%  drop  to  the healthy eye, blurring its central vision through pupillary dilatation and loss of accommodation.

The duration of the treatment varies according to the severity of amblyopia :

Patching vs Atropine

In occlusion therapy the treatment is gradually reduced to prevent regression (concentration for atropine, time of patching)

It is recommended to perform active visual tasks to stimulate the weak eye (reading, drawing, puzzles, etc.)

It is recommended to monitor the treatment regularly (i.e. every month) to avoid reverse amblyopia, that is the previously strong eye becomes Weaker.

Uncover how to monitor amblyopia treatments with the Sight Projections Platform